OTC: CRLBF - Cresco Labs Inc.

Yield per half year: -46.39%
Dividend yield: 0.00%
Sector: Healthcare

Cresco Labs Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 31.91 -100% -240.31 -100%
P/S 0.6169 3.22 -80.87%
P/BV 1.11 3.26 -65.9%
P/FCF 522.03 19.77 2540.27%
Ev/Ebitda -86.35 10.21 -946.05%
Ev/S 1.13 1.89 -40.18%
Ev/FCF 1277.35 17.78 7083.48%
E/P -0.4937 1.47 -133.61%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-1.39 24.68 -105.63% 10.56 -113.15%
ROE -34.71 13.16 -363.75%
ROA -12.92 6.08 -312.38%
ROIC -24.44 15.56 -257.08%
ROS -22.77 12.42 -283.29%
ROCE 0 15.07 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-62.27 6.27 -1092.85% -46.95 +32.65%
Nеt Debt/Ebitda -36.85 -5.69 547.42%
Debt/Ratio 0.4905 0.2171 125.88%
Debt/Equity 2.04 12.61 -83.79%
Debt/Net Income -3.8 15.13 -125.09%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 1.73 -100% 0 0%
Number of years of dividend growth 0 1.3 -100%
DSI 0 0.7924 -100%
Average dividend growth 0 -247.24 -100%
Average percentage for 5 years 0 2.81 -100%
Average percentage for payments 0 247.93 -100%
Difference from average difference in sector -1.73

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
497.59 96.77 414.2%
Growth impulse Ebitda in 5 years -615.05 78.13 -887.21%
Growth impulse Net Income in 5 years 308.19 88.81 247.02%
Growth impulse FCF in 5 years -100.56 62.73 -260.31%
Growth impulse EPS in 5 years 39.64 165.65 -76.07%
IP Score
3.62/10

Similar companies

Curaleaf Holdings, Inc.

Trulieve Cannabis Corp.

Teligent, Inc.

Eisai Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription